As anti-PDC-E2 antibody responses precede the induction of liver pathology [84], the period between the detection of antibody responses and the onset of biliary pathology may mark a time frame in which an application of antibiotics may halt the development of full-blown PBC, assuming that the underlying pathogenic mechanisms are triggered by a bacterial infection. The gene discussed is DLAT; the disease is primary biliary cholangitis.